Real-time enrollment status for this recurrent or refractory solid tumors clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:06 PM UTC
| NCT Number | NCT02013336 |
| Recruiting Status | Recruiting |
| Condition | Recurrent or Refractory Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | South Plains Oncology Consortium |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT02013336 is currently recruiting participants. This phase1 study for recurrent or refractory solid tumors is actively seeking new participants at 5 locations across the United States. The study is sponsored by South Plains Oncology Consortium. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02013336 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02013336 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.